NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Dynavax Technologies Corporation (NASDAQ: DVAX)
DVAX Technical Analysis
3
As on 9th Jun 2023 DVAX SHARE Price closed @ 11.39 and we RECOMMEND Sell for LONG-TERM with Stoploss of 12.03 & Sell for SHORT-TERM with Stoploss of 12.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DVAXSHARE Price
Open | 11.85 | Change | Price | % |
High | 11.85 | 1 Day | -0.42 | -3.56 |
Low | 11.27 | 1 Week | -0.04 | -0.35 |
Close | 11.39 | 1 Month | 0.97 | 9.31 |
Volume | 1258978 | 1 Year | -2.84 | -19.96 |
52 Week High 17.44 | 52 Week Low 7.45 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
DVAX Daily Charts |
DVAX Intraday Charts |
Whats New @ Bazaartrend |
DVAX Free Analysis |
|
DVAX Important Levels Intraday
RESISTANCE | 12.51 |
RESISTANCE | 12.15 |
RESISTANCE | 11.93 |
RESISTANCE | 11.71 |
SUPPORT | 11.07 |
SUPPORT | 10.85 |
SUPPORT | 10.63 |
SUPPORT | 10.27 |
DVAX Forecast April 2024
4th UP Forecast | 18.56 |
3rd UP Forecast | 16.26 |
2nd UP Forecast | 14.84 |
1st UP Forecast | 13.42 |
1st DOWN Forecast | 9.36 |
2nd DOWN Forecast | 7.94 |
3rd DOWN Forecast | 6.52 |
4th DOWN Forecast | 4.22 |
DVAX Weekly Forecast
4th UP Forecast | 15.94 |
3rd UP Forecast | 14.48 |
2nd UP Forecast | 13.58 |
1st UP Forecast | 12.68 |
1st DOWN Forecast | 10.10 |
2nd DOWN Forecast | 9.20 |
3rd DOWN Forecast | 8.30 |
4th DOWN Forecast | 6.84 |
DVAX Forecast2024
4th UP Forecast | 31.08 |
3rd UP Forecast | 24.77 |
2nd UP Forecast | 20.86 |
1st UP Forecast | 16.96 |
1st DOWN Forecast | 5.82 |
2nd DOWN Forecast | 1.92 |
3rd DOWN Forecast | -1.99 |
4th DOWN Forecast | -8.3 |
Dynavax Technologies Corporation ( NASDAQ USA Symbol : DVAX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DVAX Other Details
Segment | EQ | |
Market Capital | 2344546816.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
DVAX Address
DVAX Latest News
DVAX Business Profile
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Address: 2100 Powell Street, EmeryVille, CA, United States, 94608
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service